Orbis and Heidelberg Engineering announce new partnership at ESCRS congress

News
Article

The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.

Orbis and Heidelberg Engineering announce new partnership at ESCRS congress (Image credit: Adobe Stock/kerkezz)

(Image credit: Adobe Stock/kerkezz)

On Friday, Orbis, a global charity dedicated to fighting avoidable blindness, announced a partnership programme with Heidelberg Engineering. The announcement was made during the 41st ESCRS annual meeting. In a press release, Orbis announced the collaboration will make use of its e-learning and telemedicine platform Cybersight to train eyecare professionals.1

The global mission of Orbis seeks to serve the majority of people with vision loss and blindness; according to the non-profit, 90% of the 1.1 billion people affected live in low- or middle-income countries. Heidelberg Engineering will support live webinars via the Heidelberg Engineering Academy, with new sessions on optical coherence tomography (OCT) and related imaging technologies.

The company will also fund new research on retinoblastoma. This rare retinal cancer most commonly affects 9,000 paeditatric patients worldwide each year, most of whom are under 5 years of age. In a statement, Orbis said 92% percent of children diagnosed live in low- and middle-income countries. Barriers such as late diagnosis, limited accessibility to eye care, and lack of resources contribute to a 40% survival rate within 3 years of diagnosis.

Hunter Cherwek, MD, Vice President, Clinical Services & Technologies at Orbis International, said, “Orbis is delighted to be partnering with Heidelberg Engineering. Retinoblastoma outcomes for children in low-and-middle income countries could be significantly improved with earlier diagnosis and enhanced treatment.”

“As a global leader in imaging and health care technology, Heidelberg Engineering’s generous contribution and partnership will mean we can both offer enhanced knowledge for eye care practitioners via Cybersight, and pioneer new research that will help improve outcomes for children facing retinoblastoma across the world,” Cherwek added.

Reference
1. Leading eye care charity Orbis announces a new partnership with Heidelberg Engineering. News release. Orbis UK. Published 8 September, 2023.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.